Skip to main content
. 2021 Oct 19;63(10):1323–1331. doi: 10.1177/02841851211041832

Fig. 2.

Fig. 2.

Kaplan–Meier graph displaying survival in 83 patients with HCC with or without PPLE during TACE. HCC, hepatocellular carcinoma; PPLE, peritumoral portal lipiodol enhancement; TACE, transarterial chemoembolization.